Turnstone Biologics (TSBX) Earnings Date & Reports
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TSBX is expected to report earnings to rise 21.43% to -68 cents per share on May 19
Q1'25
Est.
$-0.68
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.15
Q1'24
Missed
by $0.08
The last earnings report on March 29 showed earnings per share of -56 cents, beating the estimate of -75 cents. With 69.24K shares outstanding, the current market capitalization sits at 9.00M.